Laurent Paulhac
 |
|---|
 |
READ: Portfolio Margining 101: A Conversation with CME Group’s Laurent Paulhac on MarketsReformWiki.com (April 2013) |
|---|
| Laurent Paulhac | |
| |
| Occupation | Senior Managing Director, Financial and OTC Products & Services |
|---|---|
| Employer | CME Group |
| Location | New York, NY |
| Website | www.cmegroup.com |
Laurent Paulhac is senior managing director, financial and OTC products and services at CME Group. He was appointed to this newly-created position in 2012 after having served as senior managing director, OTC products & services since Sept. 1, 2009. He is responsible for leading the development, execution and management of CME Group's global OTC business strategy. [1]
Background
Paulhac was previously Chief Executive Officer of Credit Market Analysis (CMA), a provider of credit derivatives market data acquired by CME Group in 2008. He continued to lead CMA initiatives within CME Group for a transitional period, but in July 2012, CME Group sold CMA to McGraw-Hill as part of the deal that created S&P Dow Jones Indices, a joint venture between CME Group and McGraw-Hill.[2] Paulhac stayed on with CME Group as head of OTC products and services.
Before joining CMA, Paulhac provided management consulting services for venture capital groups and technology companies looking to expand their businesses in financial services. In 1999, he founded Prescient Markets Inc., an electronic execution business focused on money market instruments in the U.S. In 2002, Prescient Markets was acquired by SunGard Data Systems, and Paulhac served as President of SunGard's STN Money Markets division until 2004. Paulhac was also a Principal of Financial Sciences Corporation, a software company providing treasury management systems to global banks and corporations.
Education
Paulhac holds a bachelor's degree in Computer Science from Columbia University.
References
- ↑ Management Team. CME Group.
- ↑ CME Group to Acquire Credit Market Analysis. Bloomberg.
